Louisiana, along with other southern and southwestern US states, topped the Walgreens Flu Index report for highest incidences of flu for November.
A new study shows increases in the misuse of non-opioid medications among US adults coinciding with decreases in opioid prescribing.
The FDA issued warning letters to several companies marketing their CBD products in ways that violate the Federal Food, Drug, and Cosmetic Act.
The drug store retailer aims to help patients get started on the most appropriate therapy sooner.
Currently only approved for men and transgender women; future trials expected.
Authorized generics have been gaining popularity with pharmaceutical manufacturers, but just how do they impact pharmacies?
The DEA had access to information about where opioids were being sold, but didn’t act on it. Why?
The Medicare for All debate surrounds the 2020 election—but is it truly understood?
Fentanyl citrate and ephedrine sulfate are among the medications affected.
Because the disease in males is rare, they have historically been excluded from clinical trials of breast cancer drugs.